OABI Q4 2025 Earnings — OmniAb, Inc. Revenue & Financial Results | Market Cap Arena

OABIOmniAb, Inc.

$231M

Q4 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M-22.5% YoY

Gross Profit

$8M99.9% margin

Operating Income

-$16M-188.2% margin

Net Income

-$14M-169.3% margin

EPS (Diluted)

$-0.11

QoQ Revenue Growth

+274.1%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$301M

Total Liabilities

$34M

Stockholders' Equity

$267M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$11M	-22.5%
Gross Profit	$8M	$11M	-22.6%
Operating Income	-$16M	-$16M	+0.7%
Net Income	-$14M	-$13M	-8.5%

Revenue Segments

Service

$2M91%

Royalty

$218,0009%